Navigation Links
Filtrona Porous Technologies präsentiert neue medizinische Schäume und einzigartige Faserprodukte für saubere Arbeitsumgebungen auf MEDICA / COMPAMED-Messe
Date:11/14/2012

RICHMOND, Virginia, 14. November 2012 /PRNewswire/ -- Filtrona Porous Technologies, ein Entwickler und Hersteller von kundenspezifischen Flüssigkeitsförderkomponenten, die in Produkten des täglichen Lebens weltweit vorkommen, wird auf der MEDICA / COMPAMED-Messe, die vom 14. bis zum 16. November 2012 in Düsseldorf stattfindet, eine Reihe neuartiger Technologien vorstellen, darunter Verbundfasern, Schaumstoffe auf Polyurethanbasis für die spezielle Wundversorgung, gesinterte poröse Kunststoffe, Reinraum-Wischmaterialien und Markenschutzprodukte.

(Logo: http://photos.prnewswire.com/prnh/20110915/PH69155LOGO)

Zu den Innovationen, die auf der Messe vorgestellt werden, gehören geformte und thermo-formbare medizinische Schaumstoffe und spezielle Wischmaterialien für den Einsatz im sauberen Arbeitsumfeld der Medizin und der Biowissenschaft. Diese Produkte sowie weitere Technologien werden am Stand von Filtrona Porous Technologies ausgestellt.

Die neuen Entwicklungen im Bereich medizinischer Qualitäts-Schäume wurden im Hinblick auf die Anforderungen der Branche konzipiert und erweitern die Produktpalette an maßgeschneiderten Lösungen für die moderne Wundversorgung und andere medizinische Anwendungen, welche einzigartige Formen, Haltbarkeit und erhöhte Funktionalität erfordern. Filtrona Porous Technologies bietet mit seinem Technologie-Portfolio an hydrophilen Schaumstoffen, Verbundfasern und porösen Kunststoffen branchenweite Lösungen.

Besucher sind eingeladen, Filtrona Porous Technologies auf der COMPAMED in Halle 8a, Stand C14, zu besuchen, um die neuesten Technologie-Plattformen zu sehen und aus erster Hand zu erleben, wie das Filtrona Porous Technologies-Team mit den Kunden zusammenarbeitet, um Lösungen für deren individuelle Anforderungen an die Flüssigkeitsförderung zu entwickeln.

Weitere Informationen finden Sie auf:

SOURCE Filtrona Porous Technologies
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Filtrona Porous Technologies Introduces New Medical-Grade Foams And Unique Fiber Products For Clean Environments At MEDICA / COMPAMED Trade Fair
2. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
3. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
4. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
5. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
6. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
7. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
8. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
9. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
10. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
11. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... treat obesity, metabolic diseases and other gastrointestinal disorders, today ... President and Chief Executive Officer, is scheduled to present ... Conference on Thursday, August 13, 2015 at 11:30 pm ... MA. Dr. Knudson will ...
(Date:8/5/2015)... BANGALORE , August 5, 2015 ... Ampoules and Blister Packaging Market segmented by Packaging ... Blister (PP, PET, PVC) - By Geographical Region ( ... , APAC, Middle East & ... Profiles, Global Market Size, Forecasts & Analysis (2015-2020). ...
(Date:8/4/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... (UCSD) of its intent to end its contract with ... in Asymptomatic Alzheimer,s disease (A4) study. The A4 study ... preclinical stage of Alzheimer,s disease in older individuals who ... PET scan, but do not show symptoms of memory ...
Breaking Medicine Technology:EnteroMedics to Present at the Canaccord Genuity 35th Annual Growth Conference 2EnteroMedics to Present at the Canaccord Genuity 35th Annual Growth Conference 3DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 2DuPont, Mitsubishi Chemical Holdings and Amcor Among Other Organizations are Expected to Invest in the Asia-Pacific and Latin American Ampoules Packaging Market 3Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3
... ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 ... of an agreement to provide extended bioinformatics genomics services ... at Ambry. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ... team at Ambry has been providing genomics solutions on ...
... , DOYLESTOWN, Pa., ... Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced ... opportunities to develop prescription pharmaceutical and OTC products and has ... primarily on the OTC/Personal Care marketplace, which may include but ...
Cached Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3
(Date:8/5/2015)... ... 05, 2015 , ... Employee Fiduciary has announced the launch ... Financial is a registered investment advisor, serving 401k and other types of retirement ... values and services , providing low-cost, fiduciary–grade investment advice to its clients. ...
(Date:8/5/2015)... ... August 05, 2015 , ... The June 6 opening of Chicago’s new elevated trail, ... didn’t escape the notice of a group of walkers at Sedgebrook senior living community in ... in Lake County’s nearby forest preserves and twice per month to more distant places. ...
(Date:8/5/2015)... ... , ... Stelari introduces their new collection, The Earth’s Song, inspired by the ... Earth’s Song. Combining fashion and activewear, Stelari’s new collection let’s you take your bohemian ... this collection is sure to make the spirit seeker swoon with prints as meaningful ...
(Date:8/5/2015)... ... August 05, 2015 , ... As the nation’s ... awareness, education and support in order to reduce the incidence of brain aneurysms ... this year it has awarded the most funding in the 20-year history of ...
(Date:8/4/2015)... ... August 05, 2015 , ... MONTICELLO, Fla. – After completing 2,400 hours in ... Hospital, this journey as a clinician allowed Dr. Barbara Thomas-Reddick to gain ... to care for patients, families, friends and staff, and she was able to witness ...
Breaking Medicine News(10 mins):Health News:Employee Fiduciary Announces Subsidiary 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3
... ... of world attention. African leaders resident in the U.S. Capitol re-committed to mobilize ... Goals (MDGs) and to replenish The Global Fund to fight AIDS, Tuberculosis and Malaria ... Washington, DC ...
... A trial on shunts used to direct blood flow ... of Michigan,s C.S. Mott Children,s Hospital, will lead to ... heart syndrome, the most common severe heart birth defect. ... the first multi-institutional randomized prospective trial ever conducted in ...
... better treatments down the road, researchers say , WEDNESDAY, ... and geneticists have identified a genetic mutation that appears ... the most common major birth defect. , Congenital heart ... explored compared to diseases like cancer, according to study ...
... -- New research illustrates that some patients with transformed ... with few side effects. The international study, involving ... will be presented at the American Society of Clinical ... in Chicago. Forty-five percent of patients with ...
... PHILADELPHIA - Genetic researchers from the University of Pennsylvania ... of Africa with human genetic data to shed light ... all human activity emerged. The study reveals not ... also the importance of having independent lines of evidence ...
... prescription under trade name Xenical and over-the-counter as Alli ... reports of rare but sometimes severe cases of liver ... for a widely used weight-loss drug. , The drug, ... Xenical and over-the-counter as Alli. , Thirteen cases of ...
Cached Medicine News:Health News:UN Foundation President Timothy E. Wirth Commends African Leaders for Renewed Commitment to the Global Fund to Fight AIDS, Tuberculosis and Malaria 2Health News:Ground-breaking study to improve quality of life and outcomes for kids born with heart defect 2Health News:Ground-breaking study to improve quality of life and outcomes for kids born with heart defect 3Health News:Gene Mutation Linked to Congenital Heart Disease 2Health News:Study identifies promising treatment for aggressive lymphoma 2Health News:Genetic data added to archaeology and linguistics to get picture of African population history 2Health News:Genetic data added to archaeology and linguistics to get picture of African population history 3Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 2Health News:Rare Cases of Liver Damage Tied to Weight-Loss Drug 3
... RNA from agarose gels to hybridization membranes ... speed and efficiency of transfer by allowing ... ,Part of an integrated system allowing electrophoresis, ... 2.5 hours, versus 29 hours required for ...
Trans-Blot Plus Gel/Cassette Assembly Tray...
PosiBlot 30-30 Masks...
A blotter fit for use with the incredible new Criterion precast gel system, the Criterion blotter combines excellent blotting efficiency with the flexibility of the Trans-Blot system and the ease-of-...
Medicine Products: